Upward Trends in Breast Cancer Incidence Continuing Among Women
Although mortality rates are down overall, progress has not been experienced by all women, with racial disparities still seen
Study Looks at Efficacy of Hemoglobin Thresholds for Transfusion
30-day risk for death/MI increased with lower hemoglobin thresholds for transfusion in patients with acute MI, anemia
No Infections Seen After Transperineal Biopsy for Prostate Cancer
Similar cancer detection rates seen for transperineal versus transrectal biopsy, but reduction in infections seen for transperineal
Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
Recovery incorporating the delayed diagnoses from 2020 was not seen for overall cancer incidence
Omitting Biopsy With Negative MRI Reduces Detection of Clinically Insignificant Prostate Cancer
More than half of diagnoses of clinically insignificant prostate cancer eliminated by omitting biopsy in men with negative MRI
Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
Intervention includes six-week in-home, voice-activated cognitive behavioral therapy program
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma
Fidanacogene Elaparvovec Superior to Prophylaxis for Hemophilia B
Adeno-associated virus gene-therapy vector for hemophilia B superior for reducing annualized bleeding rate
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions
